Pardes Biosciences, Inc. (PRDS) Social Stream
PARDES BIOSCIENCES INC (PRDS) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering PARDES BIOSCIENCES INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-18 | 1 | $25 | $25 | $25 | $2.16 | 1057.41% |
| 2022-05-10 | 2 | $20 | $18 | $19 | $2.16 | 779.63% |
| 2022-11-08 | 2 | $12 | $10 | $11 | $2.16 | 409.26% |
| 2022-12-13 | 3 | $12 | $9 | $10.333 | $2.16 | 378.38% |
| 2023-03-15 | 3 | $10 | $9 | $9.333 | $2.16 | 332.08% |
| 2023-04-03 | 2 | $9 | $1.25 | $5.125 | $2.16 | 137.27% |
| 2023-05-05 | 3 | $9 | $1.25 | $4.083 | $2.16 | 89.03% |
| NA | 1 | $NA | $NA | $NA | $2.16 | NA% |
The Trend in the Analyst Price Target
PRDS's average price target has moved down $6.92 over the prior 28 weeks.
Over the past 33 weeks, PRDS's average upside potential has been 473.33%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-10-20 | 2 | 12 | 10.00 | 11.000 | 1.45 | 658.62% |
| 2022-11-08 | 2 | 12 | 10.00 | 11.000 | 1.06 | 937.74% |
| 2022-11-08 | 3 | 12 | 10.00 | 11.000 | 1.06 | 937.74% |
| 2023-04-05 | 3 | 9 | 1.25 | 4.083 | 1.54 | 165.13% |
| 2023-05-05 | 3 | 9 | 1.25 | 4.083 | 1.90 | 114.89% |
PRDS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.33 | 1 | 0 | 2 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
PRDS's average broker recommendation rating worsened by 1.33 over the prior 26 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- PRDS has a greater number of analysts covering the stock than 47.27% of all US stocks.
- In the context of all US stocks, PARDES BIOSCIENCES INC's upside potential (average analyst target price relative to current price) is higher than 909.51% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, PARDES BIOSCIENCES INC's variance in analysts' estimates is lower than -160.73% of them.
- In the context of Healthcare stocks, PARDES BIOSCIENCES INC's average analyst price target is greater than 221.33% of them.
In the Pharmaceutical Products industry, CNTB, LVTX, and EWTX are the three stocks most similar to PARDES BIOSCIENCES INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is PRDS a Buy, Hold or Sell? See the POWR Ratings now!